Copyright Reports & Markets. All rights reserved.

Global Osteoporosis Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Osteoporosis Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Bisphosphonates
      • 1.4.3 Parathyroid Hormone Therapy
      • 1.4.4 Calcitonin
      • 1.4.5 Selective Estrogen Inhibitors Modulator (SERM)
    • 1.5 Market by Application
      • 1.5.1 Global Osteoporosis Treatment Market Share by Application (2019-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinic
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Osteoporosis Treatment Market Size
    • 2.2 Osteoporosis Treatment Growth Trends by Regions
      • 2.2.1 Osteoporosis Treatment Market Size by Regions (2019-2025)
      • 2.2.2 Osteoporosis Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Osteoporosis Treatment Market Size by by Players
      • 3.1.1 Global Osteoporosis Treatment Revenue by by Players (2014-2019)
      • 3.1.2 Global Osteoporosis Treatment Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Osteoporosis Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Osteoporosis Treatment Key Players Head office and Area Served
    • 3.3 Key Players Osteoporosis Treatment Product/Solution/Service
    • 3.4 Date of Enter into Osteoporosis Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Osteoporosis Treatment Market Size by Type (2014-2019)
    • 4.2 Global Osteoporosis Treatment Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Osteoporosis Treatment Market Size (2014-2019)
    • 5.2 Osteoporosis Treatment Key Players in North America
    • 5.3 North America Osteoporosis Treatment Market Size by Type
    • 5.4 North America Osteoporosis Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Osteoporosis Treatment Market Size (2014-2019)
    • 6.2 Osteoporosis Treatment Key Players in Europe
    • 6.3 Europe Osteoporosis Treatment Market Size by Type
    • 6.4 Europe Osteoporosis Treatment Market Size by Application

    7 China

    • 7.1 China Osteoporosis Treatment Market Size (2014-2019)
    • 7.2 Osteoporosis Treatment Key Players in China
    • 7.3 China Osteoporosis Treatment Market Size by Type
    • 7.4 China Osteoporosis Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Osteoporosis Treatment Market Size (2014-2019)
    • 8.2 Osteoporosis Treatment Key Players in Japan
    • 8.3 Japan Osteoporosis Treatment Market Size by Type
    • 8.4 Japan Osteoporosis Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Osteoporosis Treatment Market Size (2014-2019)
    • 9.2 Osteoporosis Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Osteoporosis Treatment Market Size by Type
    • 9.4 Southeast Asia Osteoporosis Treatment Market Size by Application

    10 India

    • 10.1 India Osteoporosis Treatment Market Size (2014-2019)
    • 10.2 Osteoporosis Treatment Key Players in India
    • 10.3 India Osteoporosis Treatment Market Size by Type
    • 10.4 India Osteoporosis Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Osteoporosis Treatment Market Size (2014-2019)
    • 11.2 Osteoporosis Treatment Key Players in Central & South America
    • 11.3 Central & South America Osteoporosis Treatment Market Size by Type
    • 11.4 Central & South America Osteoporosis Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Allergan Plc
      • 12.1.1 Allergan Plc Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Osteoporosis Treatment Introduction
      • 12.1.4 Allergan Plc Revenue in Osteoporosis Treatment Business (2014-2019))
      • 12.1.5 Allergan Plc Recent Development
    • 12.2 Amgen, Inc.
      • 12.2.1 Amgen, Inc. Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Osteoporosis Treatment Introduction
      • 12.2.4 Amgen, Inc. Revenue in Osteoporosis Treatment Business (2014-2019)
      • 12.2.5 Amgen, Inc. Recent Development
    • 12.3 Actavis Plc.
      • 12.3.1 Actavis Plc. Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Osteoporosis Treatment Introduction
      • 12.3.4 Actavis Plc. Revenue in Osteoporosis Treatment Business (2014-2019)
      • 12.3.5 Actavis Plc. Recent Development
    • 12.4 Eli Lilly and Company
      • 12.4.1 Eli Lilly and Company Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Osteoporosis Treatment Introduction
      • 12.4.4 Eli Lilly and Company Revenue in Osteoporosis Treatment Business (2014-2019)
      • 12.4.5 Eli Lilly and Company Recent Development
    • 12.5 F. Hoffmann La Roche Ltd.
      • 12.5.1 F. Hoffmann La Roche Ltd. Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Osteoporosis Treatment Introduction
      • 12.5.4 F. Hoffmann La Roche Ltd. Revenue in Osteoporosis Treatment Business (2014-2019)
      • 12.5.5 F. Hoffmann La Roche Ltd. Recent Development
    • 12.6 GlaxoSmithKline Pharmaceutical Ltd.
      • 12.6.1 GlaxoSmithKline Pharmaceutical Ltd. Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Osteoporosis Treatment Introduction
      • 12.6.4 GlaxoSmithKline Pharmaceutical Ltd. Revenue in Osteoporosis Treatment Business (2014-2019)
      • 12.6.5 GlaxoSmithKline Pharmaceutical Ltd. Recent Development
    • 12.7 Merck & Co AG
      • 12.7.1 Merck & Co AG Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Osteoporosis Treatment Introduction
      • 12.7.4 Merck & Co AG Revenue in Osteoporosis Treatment Business (2014-2019)
      • 12.7.5 Merck & Co AG Recent Development
    • 12.8 Novartis AG
      • 12.8.1 Novartis AG Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Osteoporosis Treatment Introduction
      • 12.8.4 Novartis AG Revenue in Osteoporosis Treatment Business (2014-2019)
      • 12.8.5 Novartis AG Recent Development
    • 12.9 Novo Nordisk A/S
      • 12.9.1 Novo Nordisk A/S Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Osteoporosis Treatment Introduction
      • 12.9.4 Novo Nordisk A/S Revenue in Osteoporosis Treatment Business (2014-2019)
      • 12.9.5 Novo Nordisk A/S Recent Development
    • 12.10 Pfizer, Inc.
      • 12.10.1 Pfizer, Inc. Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Osteoporosis Treatment Introduction
      • 12.10.4 Pfizer, Inc. Revenue in Osteoporosis Treatment Business (2014-2019)
      • 12.10.5 Pfizer, Inc. Recent Development
    • 12.11 Teva Pharmaceuticals Industries Ltd.

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Osteoporosis is a bone disease causing loss of bone density that occurs with age. It leads to million broken bones each year, and thus major reason of fractures, spinal problems, back pain, and loss of independence.
      In 2018, the global Osteoporosis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Osteoporosis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Osteoporosis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Allergan Plc
      Amgen, Inc.
      Actavis Plc.
      Eli Lilly and Company
      F. Hoffmann La Roche Ltd.
      GlaxoSmithKline Pharmaceutical Ltd.
      Merck & Co AG
      Novartis AG
      Novo Nordisk A/S
      Pfizer, Inc.
      Teva Pharmaceuticals Industries Ltd.

      Market segment by Type, the product can be split into
      Bisphosphonates
      Parathyroid Hormone Therapy
      Calcitonin
      Selective Estrogen Inhibitors Modulator (SERM)

      Market segment by Application, split into
      Hospitals
      Clinic
      Others

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Osteoporosis Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Osteoporosis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Osteoporosis Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now